SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001493152-22-011736
Filing Date
2022-05-02
Accepted
2022-05-02 09:26:18
Documents
4
Period of Report
2022-05-02

Document Format Files

Seq Description Document Type Size
1 def14a.htm DEF 14A 349827
2 def14a_001.jpg GRAPHIC 2517
3 proxy_001.jpg GRAPHIC 1193691
4 proxy_002.jpg GRAPHIC 1370765
  Complete submission text file 0001493152-22-011736.txt   3883720
Mailing Address 7946 IVANHOE AVENUE SUITE 201 LA JOLLA CA 92037
Business Address 7946 IVANHOE AVENUE SUITE 201 LA JOLLA CA 92037 (858) 263-4196
Ensysce Biosciences, Inc. (Filer) CIK: 0001716947 (see all company filings)

IRS No.: 822755287 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38306 | Film No.: 22879690
SIC: 2834 Pharmaceutical Preparations